Long-Term Quality of Life and Pregnancy Outcomes of Differentiated Thyroid Cancer Survivors Treated by Total Thyroidectomy and I131 during Adolescence and Young Adulthood
Table 3
Pregnancy outcomes after administration of I131 in subjects diagnosed with differentiated thyroid cancer before age of 25 years.
Cumulative dose of I131
≤3.85 GBq ()
>3.85 GBq ()
Maternal age at pregnancy (yrs)
26.3 ± 5.1
27.3 ± 2.4
Interval between I131 and pregnancy (months)
69.7 ± 47.8
75.3 ± 64.8
Cumulative dose of I131 before pregnancy†
3.74 ± 0.08†
7.88 ± 1.3†
Intention to have children
Patients already having children
6
15
Patients without children
12
12
Fertility problems after I131
Pregnancy after intrauterine insemination
2
0
Pregnancy after FIV ICSI
1 (ongoing)
0
Dysovulation
0
1
Pregnancy outcomes
Voluntary abortion
0
0
Miscarriage during the first trimester
1
5
Medical abortion
0
1
Live births
9
24
Birth term (weeks)
40 ± 1.2
38.7 ± 2.4
Birth weight (g)
3.256 ± 0.2
3.116 ± 0.6
Gender (male)
5
15
Number of patients having children
6
15
Number of children after I131
9
24
: number of subjects. Data are presented as mean (±SD) or number (percentage). †.